首页> 外国专利> Crystalline Salt and polymorphic forms of 4 - (5 - fluoro - 2.4 - 7 - amino - 1,4 - dihydro - 2H - quinazolin - 3 - yl) - phenyl - 5 - Chloro - thiophen-2-yl - sulfonyl urea, Pharmaceutical compositions that contain, method for Preparation and use of in the treatment of cardiovascular disease Associated

Crystalline Salt and polymorphic forms of 4 - (5 - fluoro - 2.4 - 7 - amino - 1,4 - dihydro - 2H - quinazolin - 3 - yl) - phenyl - 5 - Chloro - thiophen-2-yl - sulfonyl urea, Pharmaceutical compositions that contain, method for Preparation and use of in the treatment of cardiovascular disease Associated

机译:[4-(5-氟-2.4-[7-氨基-1,4-二氢-2H-喹唑啉-3-酰基)-苯基]-5-氯-噻吩-2-基-磺酰基的盐和多晶型物尿素,含有的药物组合物,其制备方法和在相关心血管疾病的治疗中的用途

摘要

Crystalline polymorphic forms, D, a, C, which correspond to salts of potassium, sodium, calcium and tromethamine. Claim 1: a Salt comprising a compound of the formula (1) and an ion selected from the group consisting of sodium, potassium, calcium, l-lysine, ammonium, Magnesium, l-arginine, tromethamine, N - etilglucamina and n-methylglucamine.
机译:结晶多晶型物D,a,C,分别对应于钾,钠,钙和氨丁三醇的盐。权利要求1:一种盐,其包含式(1)的化合物和选自钠,钾,钙,l-赖氨酸,铵,镁,l-精氨酸,氨丁三醇,N-艾替葡糖胺和n-甲基葡糖胺的离子的盐。

著录项

  • 公开/公告号AR075097A1

    专利类型

  • 公开/公告日2011-03-09

    原文格式PDF

  • 申请/专利权人 PORTOLA PHARMACEUTICALS INC;

    申请/专利号AR2009P104261

  • 发明设计人

    申请日2009-11-04

  • 分类号C07D409/12;A61K31/381;A61K31/517;A61P7/02;A61P7/04;A61P9/10;A61P9/14;

  • 国家 AR

  • 入库时间 2022-08-21 18:07:30

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号